Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mendelian randomization explores the causal relationships between obesity, diabetes, inflammation and nonalcoholic fatty liver disease. | Medicine (Baltimore) | 2023 | 37747017 | PubTator, text mining | PubMed |
| Micropatterned primary hepatocyte co-culture (HEPATOPAC) for fatty liver disease modeling and drug screening. | Sci Rep | 2023 | 37739978 | PubTator, text mining | PubMed |
| The Model for End-stage Liver Disease 3.0 is not superior to the Model for End-stage Liver Disease-Na in predicting survival: A retrospective cohort study. | Hepatol Commun | 2023 | 37738412 | PubTator, text mining | PubMed |
| Exposure to ambient air pollutants, serum miRNA networks, lipid metabolism, and non-alcoholic fatty liver disease in young adults. | Ecotoxicol Environ Saf | 2023 | 37729806 | PubTator, text mining | PubMed |
| Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options. | Cell Adh Migr | 2023 | 37726886 | PubTator, text mining | PubMed |
| Study on inflammation and fibrogenesis in MAFLD from 2000 to 2022: a bibliometric analysis. | Front Endocrinol (Lausanne) | 2023 | 37720529 | PubTator, text mining | PubMed |
| NASH Drug Development: Seeing the Light at the End of the Tunnel? | J Clin Transl Hepatol | 2023 | 37719961 | PubTator, text mining | PubMed |
| The genetics of portal hypertension: Recent developments and the road ahead. | Liver Int | 2023 | 37718732 | PubTator, text mining | PubMed |
| Usefulness of PNPLA3 variant for predicting hepatic events in steatotic liver disease: a matter of ethnicity or baseline risk? | Liver Int | 2023 | 37718719 | PubTator, text mining | PubMed |
| Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD. | Front Endocrinol (Lausanne) | 2023 | 37711901 | PubTator, text mining | PubMed |
| European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation. | Transpl Int | 2023 | 37711401 | PubTator, text mining | PubMed |
| Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease. | Nat Genet | 2023 | 37709864 | PubTator, text mining | PubMed |
| Aspirin is associated with a reduced incidence of liver disease in men. | Hepatol Commun | 2023 | 37708453 | PubTator, text mining | PubMed |
| Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review. | J Obes Metab Syndr | 2023 | 37700494 | PubTator, text mining | PubMed |
| The Effect of Vitamin E Supplementation on Serum Aminotransferases in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review and Meta-Analysis. | Nutrients | 2023 | 37686767 | PubTator, text mining | PubMed |
| The Prognostic Value of ASPHD1 and ZBTB12 in Colorectal Cancer: A Machine Learning-Based Integrated Bioinformatics Approach. | Cancers (Basel) | 2023 | 37686578 | PubTator, text mining | PubMed |
| Evaluation of Human Hepatocyte Drug Metabolism Carrying High-Risk or Protection-Associated Liver Disease Genetic Variants. | Int J Mol Sci | 2023 | 37686209 | PubTator, text mining | PubMed |
| Saturated Fat-Mediated Upregulation of IL-32 and CCL20 in Hepatocytes Contributes to Higher Expression of These Fibrosis-Driving Molecules in MASLD. | Int J Mol Sci | 2023 | 37686029 | PubTator, text mining | PubMed |
| Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive review. | J Int Med Res | 2023 | 37676968 | PubTator, text mining | PubMed |
| Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPARγ and SREBP2. | JHEP Rep | 2023 | 37675273 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=31